Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-low doses of Gelsemium sempervirens

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Marzotto, Marta ^a   Olioso, Debora ^a   Brizzi, Maurizio ^b   Tononi, Paola ^a   Cristofoletti, Mirco ^a   Bellavite, Paolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN LIKE 7B; ALPHA KINASE 3; ALPHA S1 CASEIN; CALCIUM; CD163 ANTIGEN; COMPLEMENTARY DNA; CYTOTOXIC AGENT; DECTIN 1; DOCKING PROTEIN 5; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 25; GALANIN RECEPTOR 2; GELSEMIUM SEMPERVIRENS EXTRACT; LYSOPHOSPHOLIPASE; MUCIN 2; MYELOPEROXIDASE; NEUROPEPTIDE RECEPTOR; PLANT EXTRACT; PROTOCADHERIN; TACHYKININ 4; TRANSCRIPTOME; TRANSMEMBRANE PROTEIN 40; UNCLASSIFIED DRUG; ALKALOID; ANXIOLYTIC AGENT; GELSEMINE; MATERIA MEDICA;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFICACY; GELSEMIUM; GELSEMIUM SEMPERVIRENS; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MEDICINAL PLANT; MICROARRAY ANALYSIS; NERVE CELL; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; CHEMISTRY; DRUG EFFECTS; GENETICS; HOMEOPATHY; METABOLISM; SIGNAL TRANSDUCTION;

ALKALOIDS; ANTI-ANXIETY AGENTS; GELSEMIUM; GENE EXPRESSION; HOMEOPATHY; HUMANS; MATERIA MEDICA; NEURONS; PLANT EXTRACTS; RECEPTORS, NEUROPEPTIDE; SIGNAL TRANSDUCTION;

EID: 84899139497     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-104     Document Type: Article

References (89)

1. Schun Y, Cordell GA. Cytotoxic steroids of Gelsemium sempervirens. J Nat Prod 1987, 50:195-198. 10.1021/np50050a012, 3655795.
2. Dutt V, Thakur S, Dhar VJ, Sharma A. The genus Gelsemium: an update. Pharmacogn Rev 2010, 4:185-194. 10.4103/0973-7847.70916, 3249920, 22228960.
3. Jin GL, Su YP, Liu M, Xu Y, Yang J, Liao KJ, Yu CX. Medicinal plants of the genus Gelsemium (Gelsemiaceae, Gentianales)-a review of their phytochemistry, pharmacology, toxicology and traditional use. J Ethnopharmacol 2014, doi:10.1016/j.jep.2014.01.003.
4. Valnet J. Phytothérapie 1992, Paris: Maloine.
5. Peredery O, Persinger MA. Herbal treatment following post-seizure induction in rat by lithium pilocarpine: Scutellaria lateriflora (Skullcap), Gelsemium sempervirens (Gelsemium) and Datura stramonium (Jimson Weed) may prevent development of spontaneous seizures. Phytother Res 2004, 18:700-705. 10.1002/ptr.1511, 15478209.
6. Boericke W. Materia Medica with Repertory 1927, Philadelphia: Boericke & Tafel, Inc.
7. Binsard AM, Guillemain J, Platel A, Savini EC, Tetau M. Etude psycho-pharmacologique de dilutions homéopathiques de Gelsemium et d'Ignatia. Ann Homeop Fr 1980, 22:35-50.
8. Guillemain J, Rousseau A, Dorfman P, Tetau M. Recherche en psychopharmacologie. Cah Biother 1989, 103:53-66.
9. Guermonprez M. Homéopathie, Principles - Clinique - Techniques 2006, Paris: CEDH.
10. Bellavite P, Magnani P, Marzotto M, Conforti A. Assays of homeopathic remedies in rodent behavioural and psychopathological models. Homeopathy 2009, 98:208-227. 10.1016/j.homp.2009.09.005, 19945676.
11. Gahlot K, Abid M, Sharma A. Pharmacological evaluation of Gelsemium sempervirens roots for CNS depressant activity. Int J Pharm Tech Res 2012, 3:693-697.
12. Dutt V, Dhar VJ, Sharma A. Antianxiety activity of Gelsemium sempervirens. Pharm Biol 2010, 48:1091-1096. 10.3109/13880200903490521, 20860436.
13. Liu M, Shen J, Liu H, Xu Y, Su YP, Yang J, Yu CX. Gelsenicine from Gelsemium elegans attenuates neuropathic and inflammatory pain in mice. Biol Pharm Bull 2011, 34:1877-1880. 10.1248/bpb.34.1877, 22130245.
14. Liu M, Huang HH, Yang J, Su YP, Lin HW, Lin LQ, Liao WJ, Yu CX. The active alkaloids of Gelsemium elegans Benth. are potent anxiolytics. Psychopharmacology (Berl) 2013, 225:839-851. 10.1007/s00213-012-2867-x, 23052566.
15. Zhang JY, Gong N, Huang JL, Guo LC, Wang YX. Gelsemine, a principal alkaloid from Gelsemium sempervirens Ait., exhibits potent and specific antinociception in chronic pain by acting at spinal alpha3 glycine receptors. Pain 2013, 154:2452-2462. 10.1016/j.pain.2013.07.027, 23886522.
16. Meyer L, Boujedaini N, Patte-Mensah C, Mensah-Nyagan AG. Pharmacological effect of gelsemine on anxiety-like behavior in rat. Behav Brain Res 2013, 253:90-94.
17. Bhattacharyya SS, Mandal SK, Biswas R, Paul S, Pathak S, Boujedaini N, Belon P, Khuda-Bukhsh AR. In vitro studies demonstrate anticancer activity of an alkaloid of the plant Gelsemium sempervirens. Exp Biol Med (Maywood) 2008, 233:1591-1601. 10.3181/0805-RM-181, 18997108.
18. Zhao QC, Hua W, Zhang L, Guo T, Zhao MH, Yan M, Shi GB, Wu LJ. Antitumor activity of two gelsemine metabolites in rat liver microsomes. J Asian Nat Prod Res 2010, 12:731-739. 10.1080/10286020.2010.492951, 20839118.
19. Rammal H, Soulimani R. Effects of high doses of Gelsemium sempervirens L. on GABA receptor and on the cellular and humoral immunity in mice. J Med Med Sci 2010, 1:40-44.
20. Xu YK, Liao SG, Na Z, Hu HB, Li Y, Luo HR. Gelsemium alkaloids, immunosuppressive agents from Gelsemium elegans. Fitoterapia 2012, 83:1120-1124. 10.1016/j.fitote.2012.04.023, 22579843.
21. Roy R, Tiller W, Bell IR, Hoover MR. The structure of liquid water. Novel insights from materials research; potential relevance to homeopathy. Mat Res Innovat 2005, 9:98-103.
22. Yinnon TA, Yinnon CA. Electric dipole aggregates in very diluted polar liquids: theory and experimental evidence. Int J Mod Phys B 2011, 25:3707-3743.
23. Bell IR, Koithan M. A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system. BMC Complement Altern Med 2012, 12:191. 10.1186/1472-6882-12-191, 3570304, 23088629.
24. Endler P, Thieves K, Reich C, Matthiessen P, Bonamin L, Scherr C, Baumgartner S. Repetitions of fundamental research models for homeopathically prepared dilutions beyond 10(-23): a bibliometric study. Homeopathy 2010, 99:25-36. 10.1016/j.homp.2009.11.008, 20129174.
25. Stock-Schroer B, Albrecht H, Betti L, Dobos G, Endler C, Linde K, Lüdtke R, Musial F, van Wijk R, Witt C, Baumgartner S. Reporting experiments in homeopathic basic research-description of the checklist development. Evid Based Complement Alternat Med 2011, 2011:639260. 3136753, 19884113.
26. Magnani P, Conforti A, Zanolin E, Marzotto M, Bellavite P. Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology (Berl) 2010, 210:533-545. 10.1007/s00213-010-1855-2, 2877813, 20401745.
27. Bellavite P, Conforti A, Marzotto M, Magnani P, Cristofoletti M, Olioso D, Zanolin ME. Testing homeopathy in mouse emotional response models: pooled data analysis of two series of studies. Evid Based Complement Alternat Med 2012, 2012:954374. 3324905, 22548123.
28. Sukul NC, Bala SK, Bhattacharyya B. Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology (Berl) 1986, 89:338-339.
29. Bousta D, Soulimani R, Jarmouni I, Belon P, Falla J, Foment N, Younos C. Neurotropic, immunological and gastric effects of low doses of Atropa belladonna L., Gelsemium sempervirens L. and Poumon histamine in stressed mice. J Ethnopharmacol 2001, 74:205-215. 10.1016/S0378-8741(00)00346-9, 11274819.
30. Venard C, Boujedaini N, Mensah-Nyagan AG, Patte-Mensah C. Comparative analysis of gelsemine and Gelsemium sempervirens activity on neurosteroid allopregnanolone formation in the spinal cord and limbic system. Evid Based Complement Alternat Med 2011, 407617. doi:10.1093/ecam/nep083.
31. Seo JJ, Lee SH, Lee YS, Kwon BM, Ma Y, Hwang BY, Hong JT, Oh KW. Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1363-1369. 10.1016/j.pnpbp.2007.05.009, 17698274.
32. Donnici L, Tiraboschi E, Tardito D, Musazzi L, Racagni G, Popoli M. Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells. BMC Neurosci 2008, 9:61. 10.1186/1471-2202-9-61, 2483719, 18601743.
33. Park SW, Seo MK, Cho HY, Lee JG, Lee BJ, Seol W, Kim YH. Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells. Neuropharmacology 2011, 61:761-769. 10.1016/j.neuropharm.2011.05.022, 21663752.
34. Fisher P. What is homeopathy? An introduction. Front Biosci (Elite Ed) 2012, 4:1669-1682.
35. Anonymous Pharmacopée Homéopathique Française - X édition 2002, Saint-Denis Cedex (FR): Agence Française de Sécurité Sanitaire de Produits de Santé, Anonymous.
36. Kohl RL, Perez-Polo JR, Quay WB. Effect of methionine, glycine and serine on serine hydroxymethyltransferase activity in rat glioma and human neuroblastoma cells. J Neurosci Res 1980, 5:271-280. 10.1002/jnr.490050403, 6776288.
37. Chakravarthy B, Gaudet C, Menard M, Atkinson T, Brown L, Laferla FM, Armato U, Whitfield J. Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alzheimers Dis 2010, 19:915-925.
38. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996, 19:1518-1520. 10.1248/bpb.19.1518, 8951178.
39. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264. 10.1093/biostatistics/4.2.249, 12925520.
40. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/19.2.185, 12538238.
41. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210. 10.1093/nar/30.1.207, 99122, 11752295.
42. Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 2005, 21:2067-2075. 10.1093/bioinformatics/bti270, 15657102.
43. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statistical Soc Series B (Methodological) 1995, 57:289-300.
44. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J. TM4 microarray software suite. Methods Enzymol 2006, 411:134-193.
45. Brock G, Datta S, Pihur V, Datta S. clValid: an R package for cluster validation. J Stat Softw 2008, 25:1-22.
46. Huang D, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
47. Franco MI, Turin L, Mershin A, Skoulakis EM. Molecular vibration-sensing component in Drosophila melanogaster olfaction. Proc Natl Acad Sci USA 2011, 108:3797-3802. 10.1073/pnas.1012293108, 3048096, 21321219.
48. Tran AH, Berger A, Wu GE, Kee BL, Paige CJ. Early B-cell factor regulates the expression of Hemokinin-1 in the olfactory epithelium and differentiating B lymphocytes. J Neuroimmunol 2011, 232:41-50. 10.1016/j.jneuroim.2010.09.027, 20965576.
49. Cunin P, Caillon A, Corvaisier M, Garo E, Scotet M, Blanchard S, Delneste Y, Jeannin P. The tachykinins substance P and hemokinin-1 favor the generation of human memory Th17 cells by inducing IL-1beta, IL-23, and TNF-like 1A expression by monocytes. J Immunol 2011, 186:4175-4182. 10.4049/jimmunol.1002535, 21368235.
50. Madaan V, Wilson DR. Neuropeptides: relevance in treatment of depression and anxiety disorders. Drug News Perspect 2009, 22:319-324. 10.1358/dnp.2009.22.6.1395255, 19771321.
51. Alherbish A, Charrois TL, Ackman ML, Tsuyuki RT, Ezekowitz JA. The prevalence of natural health product use in patients with acute cardiovascular disease. PLoS ONE 2011, 6:e19623. 10.1371/journal.pone.0019623, 3090400, 21573067.
52. Barbancey J. Pratique Homéopathique en psycho-pathologie, Tome II 1987, Paris: Editions Similia.
53. Danno K, Colas A, Masson JL, Bordet MF. Homeopathic treatment of migraine in children: results of a prospective, multicenter, observational study. J Altern Complement Med 2012, 19:119-123.
54. Paris A, Gonnet N, Chaussard C, Belon P, Rocourt F, Saragaglia D, Cracowski JL. Effect of homeopathy on analgesic intake following knee ligament reconstruction: a phase III monocentre randomized placebo controlled study. Br J Clin Pharmacol 2008, 65:180-187. 10.1111/j.1365-2125.2007.03008.x, 2291233, 18251757.
55. Bellavite P, Conforti A, Piasere V, Ortolani R. Immunology and homeopathy. 1. Historical background. eCAM 2005, 2:441-452. 1297514, 16322800.
56. Shang A, Huwiler-Müntener K, Nartey L, Jüni P, Dörig S, Sterne JAC, Pewsner D, Egger M. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005, 366:726-732. 10.1016/S0140-6736(05)67177-2, 16125589.
57. Jonas WB, Kaptchuk TJ, Linde K. A critical overview of homeopathy. Ann Intern Med 2003, 138:393-399. 10.7326/0003-4819-138-5-200303040-00009, 12614092.
58. Calabrese EJ, Jonas WB. Evaluating homeopathic drugs within a biomedical framework. Hum Exp Toxicol 2010, 29:545-549. 10.1177/0960327110369775, 20558604.
59. Plant KE, Anderson E, Simecek N, Brown R, Forster S, Spinks J, Toms N, Gibson GG, Lyon J, Plant N. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol 2009, 235:124-134. 10.1016/j.taap.2008.10.019, 19101580.
60. Lai CK, Chan YW. Confirmation of Gelsemium poisoning by targeted analysis of toxic Gelsemium alkaloids in urine. J Anal Toxicol 2009, 33:56-61. 10.1093/jat/33.1.56, 19161670.
61. Calabrese EJ, Jonas WB. Homeopathy: clarifying its relationship to hormesis. Hum Exp Toxicol 2010, 29:531-536. 10.1177/0960327110369857, 20558601.
62. Iavicoli I, Calabrese EJ, Nascarella MA. Exposure to nanoparticles and hormesis. Dose Response 2010, 8:501-517. 10.2203/dose-response.10-016.Iavicoli, 2990066, 21191487.
63. Van Wijk R, Wiegant FA. Postconditioning hormesis and the homeopathic Similia principle: molecular aspects. Hum Exp Toxicol 2010, 29:561-565. 10.1177/0960327110369860, 20558607.
64. Bell IR, Schwartz GE. Adaptive network nanomedicine: an integrated model for homeopathic medicine. Front Biosci (Schol Ed) 2013, 5:685-708.
65. Venard C, Boujedaini N, Belon P, Mensah-Nyagan AG, Patte-Mensah C. Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine. Neuroscience 2008, 153:154-161. 10.1016/j.neuroscience.2008.02.009, 18367344.
66. Bellavite P, Conforti A, Pontarollo F, Ortolani R. Immunology and homeopathy. 2. Cells of the immune system and inflammation. eCAM 2006, 3:13-24. 1375241, 16550219.
67. Witt CM, Bluth M, Albrecht H, Weisshuhn TE, Baumgartner S, Willich SN. The in vitro evidence for an effect of high homeopathic potencies-a systematic review of the literature. Complement Ther Med 2007, 15:128-138. 10.1016/j.ctim.2007.01.011, 17544864.
68. Sainte-Laudy J, Belon P. Inhibition of basophil activation by histamine: a sensitive and reproducible model for the study of the biological activity of high dilutions. Homeopathy 2009, 98:186-197. 10.1016/j.homp.2009.09.009, 19945674.
69. Majewsky V, Arlt S, Shah D, Scherr C, Jager T, Betti L, Trebbi G, Bonamin L, Klocke P, Baumgartner S. Use of homeopathic preparations in experimental studies with healthy plants. Homeopathy 2009, 98:228-243. 10.1016/j.homp.2009.09.012, 19945677.
70. Bellavite P, Marzotto M, Olioso D, Moratti E, Conforti A. High-dilution effects revisited. 1. Physicochemical aspects. Homeopathy 2014, 103:4-21. 10.1016/j.homp.2013.08.003, 24439452.
71. Anick DJ, Ives JA. The silica hypothesis for homeopathy: physical chemistry. Homeopathy 2007, 96:189-195. 10.1016/j.homp.2007.03.005, 17678816.
72. Chikramane PS, Suresh AK, Bellare JR, Kane SG. Extreme homeopathic dilutions retain starting materials: A nanoparticulate perspective. Homeopathy 2010, 99:231-242. 10.1016/j.homp.2010.05.006, 20970092.
73. Relaix S, Leheny RL, Reven L, Sutton M. Memory effect in composites of liquid crystal and silica aerosil. Phys Rev E Stat Nonlin Soft Matter Phys 2011, 84:061705.
74. Baier G, Costa C, Zeller A, Baumann D, Sayer C, Araujo PH, Mailänder V, Musyanovych A, Landfester K. BSA adsorption on differently charged polystyrene nanoparticles using isothermal titration calorimetry and the influence on cellular uptake. Macromol Biosci 2011, 11:628-638. 10.1002/mabi.201000395, 21384550.
75. Bel HS, Magnin A, Petrier C, Boufi S. Starch nanoparticles formation via high power ultrasonication. Carbohydr Polym 2013, 92:1625-1632. 10.1016/j.carbpol.2012.11.022, 23399199.
76. Upadhyay RP, Nayak C. Homeopathy emerging as nano medicine. Int J High Dilution Res 2011, 10:299-310.
77. Das S, Das J, Samadder A, Bhattacharyya SS, Das D, Khuda-Bukhsh AR. Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids Surf B Biointerfaces 2013, 101:325-336.
78. Prakash DJ, Arulkumar S, Sabesan M. Effect of nanohypericum (Hypericum perforatum gold nanoparticles) treatment on restraint stressinduced behavioral and biochemical alteration in male albino mice. Pharmacognosy Res 2010, 2:330-334. 10.4103/0974-8490.75450, 3111690, 21713134.
79. Bhattacharyya SS, Paul S, Khuda-Bukhsh AR. Encapsulated plant extract (Gelsemium sempervirens) poly (lactide-co-glycolide) nanoparticles enhance cellular uptake and increase bioactivity in vitro. Exp Biol Med (Maywood ) 2010, 235:678-688. 10.1258/ebm.2010.009338, 20511672.
80. Schwartz GE, Russek LG, Bell IR, Riley D. Plausibility of homeopathy and conventional chemical therapy: the systemic memory resonance hypothesis. Med Hypotheses 2000, 54:634-637. 10.1054/mehy.1999.0913, 10859655.
81. Bellavite P. Complexity science and homeopathy. A synthetic overview. Homeopathy 2003, 92:203-212. 10.1016/j.homp.2003.08.002, 14587687.
82. Bellavite P, Olioso D, Marzotto M, Moratti E, Conforti A. A dynamic network model of the similia principle. Complement Ther Med 2013, 21:750-761. 10.1016/j.ctim.2013.09.001, 24280484.
83. Bellavite P, Marzotto M, Olioso D, Moratti E, Conforti A. High-dilution effects revisited. 2. Pharmacodynamic mechanisms. Homeopathy 2014, 103:22-43. 10.1016/j.homp.2013.08.002, 24439453.
84. Ramo P, Kesseli J, Yli-Harja O. Perturbation avalanches and criticality in gene regulatory networks. J Theor Biol 2006, 242:164-170. 10.1016/j.jtbi.2006.02.011, 16574157.
85. Likhoshvai VA, Fadeev SI, Kogai VV, Khlebodarova TM. On the chaos in gene networks. J Bioinform Comput Biol 2013, 11:1340009. 10.1142/S021972001340009X, 23427991.
86. Morita K, Tsumoto K, Aihara K. Possible effects of depolarizing GABAA conductance on the neuronal input-output relationship: a modeling study. J Neurophysiol 2005, 93:3504-3523. 10.1152/jn.00988.2004, 15689391.
87. Gupta K, Singh HP, Biswal B, Ramaswamy R. Adaptive targeting of chaotic response in periodically stimulated neural systems. Chaos 2006, 16:023116. 10.1063/1.2204749, 16822019.
88. Qi Y, Watts AL, Kim JW, Robinson PA. Firing patterns in a conductance-based neuron model: bifurcation, phase diagram, and chaos. Biol Cybern 2013, 107:15-24. 10.1007/s00422-012-0520-8, 22990669.
89. Szolnoki Z. A dynamically changing intracellular water network serves as a universal regulator of the cell: the water-governed cycle. Biochem Biophys Res Commun 2007, 357:331-334. 10.1016/j.bbrc.2007.03.161, 17420007.